Follow the people · Insider
Reid Alexander Waldman
Reid Alexander Waldman files insider transactions with the SEC as a chief executive officer of Veradermics (MANE). We hold 1 disclosed purchase or sale filed since 5 February 2026, 1 of them in the last 90 days.
- Files forMANE
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 February 2026 — 17 August 2026Chief Executive Officer · Veradermics (MANE)13 Form 4 lines · source: SEC Form 4
- Filed 29 May 2026 — 27 July 2026Director · Achieve Life Sciences (ACHV)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
16 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 3,452 shares of VeradermicsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 11,527 shares of VeradermicsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 25,234 shares of VeradermicsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 27,490 shares of VeradermicsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 3,000 shares of VeradermicsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 249 shares of VeradermicsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- exercised options over 3,452 shares of Veradermics (a derivative holding)SEC Form 418 August 2026Stock Option (Right to Buy) · traded 17 August 2026 · filed 18 August 2026
- was granted 25,000 shares of Achieve Life Sciences (a derivative holding)SEC Form 429 July 2026Stock Option (right to buy) · traded 27 July 2026 · filed 29 July 2026
- was granted 16,700 shares of Achieve Life Sciences (a derivative holding)SEC Form 429 July 2026Restricted Stock Unit (RSU) · traded 27 July 2026 · filed 29 July 2026
- was granted 47,250 shares of Achieve Life Sciences (a derivative holding)SEC Form 42 June 2026Stock Option (right to buy) · traded 29 May 2026 · filed 2 June 2026
- converted 1,437 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- converted 1,437 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series A Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- was granted 556,399 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Stock Option (Right to Buy) · traded 3 February 2026 · filed 5 February 2026
- converted 1,437 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series A Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- was granted 556,399 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Stock Option (Right to Buy) · traded 3 February 2026 · filed 5 February 2026
- converted 1,437 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.